Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for ...

The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last ...

UnitedHealthcare likely to cover Vertex’s pain drug Vertex Pharmaceuticals received FDA approval for a new non-opioid pain drug, marketed as Journavx, and it appears the nation’s largest ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Next: Access Our New, Shockingly Simple 'Alert System' RBC Capital Markets says Vertex management is optimistic about the recently approved Alyftrek. They predict that most of the 6,000 patients ...

Vertex has been running a number of trials because if there’s one thing that we can take away from the failed drug development projects of the past, it’s that there are many kinds of pain.

HOUSTON, January 22, 2025--(BUSINESS WIRE)--Vertex Energy, Inc. ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, together with its affiliates ...

Credit: Magneto Guitars NAMM 2025: Magneto will showcase two new guitars at NAMM 2025, with the Sonnet Supreme and the Ruby Bass – its first-ever bass build – given a sneak preview ahead of ...

Aside from performance in the ring, voice is a major component needed to succeed in wrestling. One word and the crowd instantly knows who it is, cheers and waits in anticipation. Think of the best ...

We knew it was coming, but Nintendo has now confirmed an exact time for its dedicated Switch 2 Direct. The company will host a Nintendo Direct focused on its upcoming Switch successor on 2nd April ...